BevacizumabFatigue and exacerbation of hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1721卷 / 1期

关键词：

D O I：

10.1007/s40278-018-52098-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[21] DiazoxidePulmonary hypertension: 2 case reports
Reactions Weekly, 2019, 1766 (1) : 119 - 119
[22] BevacizumabAllergy and hypertension: 2 case reports
Reactions Weekly, 2017, 1662 (1) : 72 - 72
[23] DifluprednateOcular hypertension: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 178 - 178
[24] NiraparibNeutropenia and hypertension: 2 case reports
Reactions Weekly, 2020, 1823 (1) : 268 - 268
[25] BevacizumabWorsened hypertension: 2 case reports
Reactions Weekly, 2019, 1776 (1) : 99 - 99
[26] AripiprazoleWorsened hypertension: 2 case reports
Reactions Weekly, 2013, 1452 (1) : 8 - 8
[27] RegdanvimabHypoxia and hypertension: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 423 - 423
[28] DexamethasoneOcular hypertension: 2 case reports
Reactions Weekly, 2021, 1840 (1) : 150 - 150
[29] BevacizumabAnaemia and hypertension: 2 case reports
Reactions Weekly, 2025, 2041 (1) : 84 - 84
[30] EverolimusAnaemia and hypertension: 2 case reports
Reactions Weekly, 2017, 1667 (1) : 146 - 146

← 1 2 3 4 5 →